Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

Koichiro Kumagai, Hideko Nakashima, Hidenori Urata, +3

Journal of the American College of Cardiology

Cardiovascular DiseaseStructural RemodelingMedicinePhysiologyReceptor Antagonist +10

Angiotensin II Antagonist Prevents Electrical Remodeling in Atrial Fibrillation

Hideko Nakashima, Koichiro Kumagai, Hidenori Urata, +3

Circulation

Twenty-Four-Hour Blood Pressure–Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension

Kazuomi Kario, Kenta Okada, Mitsutoshi Kato, +21

Circulation

Increased Chymase-Dependent Angiotensin II Formation in Human Atherosclerotic Aorta

Makoto Ihara, Hidenori Urata, Akio Kinoshita, +5

Hypertension

InflammationHypertensionVascular DiseaseHuman Atherosclerotic AortaAngiotensin Ii +11

Angiotensin II Receptors in Normal and Failing Human Hearts*

Hidenori Urata, Bernadine Healy, Robert W. Stewart, +2

The Journal of Clinical Endocrinology & Metabolism

Differences in Tissue Angiotensin II–Forming Pathways by Species and Organs In Vitro

Maki Akasu, Hidenori Urata, Akio Kinoshita, +3

Hypertension

Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial

Kazuomi Kario, Yoshiaki Yokoi, Keisuke Okamura, +39

Hypertension Research

Mast cell chymase limits the cardiac efficacy of Ang I–converting enzyme inhibitor therapy in rodents

Chih‐Chang Wei, Naoki Hase, Yukiko Inoue, +11

Journal of Clinical Investigation

Mast Cell ChymaseCardiac MuscleHeart FailureMast Cell DisorderImmunology +16

Blood pressure lowering effect of low intensity aerobic training in elderly hypertensive patients

Mitsugi Motoyama, Yoshiyuki Sunami, F Kinoshita, +7

Medicine & Science in Sports & Exercise

Dual pathway for angiotensin II formation in human internal mammary arteries

Adriaan A. Voors, Yigal M. Pinto, Hendrik Buikema, +6

British Journal of Pharmacology

Dual PathwayHypertensionCardiovascular PharmacologyAngiotensin Ii FormationPharmacotherapy +14